Frasier Syndrome Market, By Test Type (Genetic Testing, Ultrasound Testing, Others), By End User (Hospitals, Diagnostic Centers, Research Institutes, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Description

The Frasier syndrome Market size is expected to reach US$ 200.5 Mn by 2030, from US$ 141.2 Mn in 2023, at a CAGR of 5.1% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 141.2 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	5.10%	2030 Value Projection:	US$ 200.5 Mn

Figure 1. Global Frasier Syndrome Market Share (%), By Region, 2023

Frasier syndrome (FS) is a rare genetic disorder that affects the kidneys and sexual development. It is characterized by the presence of kidney disease, which can progress to end-stage renal disease, and the development of gonadal dysgenesis, leading to the absence of menstrual cycles in females.

Dr. Prader in 1964 coined the term Frasier syndrome. It is caused by mutations in the WT1 gene located on the short arm of chromosome 11. This gene plays a crucial role in the development of the kidneys and gonads during embryogenesis. Mutations in the WT1 gene disrupt normal cellular processes, leading to the characteristic features of Frasier syndrome.

The incidence of Frasier syndrome is estimated to be around 1 in 100,000 live births. It predominantly affects females, although rare cases have been reported in males as well. The diagnosis of Frasier syndrome is based on clinical features, genetic testing, and histopathological examination of kidney tissue.

Market Dynamics:

The market for Frasier syndrome is driven by several factors. Firstly, rising awareness about genetic disorders and the availability of advanced diagnostic techniques have led to an increased diagnosis rate of Frasier syndrome. This has resulted in a growing demand for genetic tests and screenings, driving market growth.

Secondly, the increasing prevalence of Frasier syndrome has also contributed to market expansion. The need for effective renal replacement therapies and long-term management strategies has created a demand for innovative treatment options.

However, the market for Frasier syndrome faces certain restraints as well. Limited awareness among healthcare professionals and the general public about this rare disorder can lead to underdiagnosis and delayed treatment. Moreover, the high cost of genetic testing and specialized treatments poses a challenge for patients and their families.

Despite these challenges, the market for Frasier syndrome presents several opportunities. The development of targeted therapies and personalized medicine approaches holds promise for improved outcomes in patients with Frasier syndrome. Furthermore, collaborations between research institutions, pharmaceutical companies, and advocacy groups can help drive research on better diagnostic tools and treatment modalities.

Key Features of the Study:

This report provides in-depth analysis of the global Frasier syndrome market, including market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global Frasier syndrome market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Frasier syndrome market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Frasier syndrome market

Frasier Syndrome Market Segmentation:

By Test Type
- Genetic Testing
- Ultrasound Testing
- Others
By End User
- Hospitals
- Diagnostic Centers
- Research Institutes
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top companies in Frasier Syndrome Market:
- Thermo Fisher Scientific
- Invitae Corporation
- GE Healthcare
- Koninklijke Philips N.V.
- Mindray Medical
- Siemens
- Canon Medical Systems Corporation
- FUJIFILM Sonosite Inc.
- ESAOTE SPA, SAMSUNGHEALTHCARE
- Empire Genomics Inc.
- BPL Medical Technologies
- Trivitron Healthcare
- Hitachi Healthcare

Product Code: CMI6286

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Frasier Syndrome, By Test Type
- Market Frasier Syndrome, By End User
- Market Frasier Syndrome, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Rising awareness about genetic disorders
- Restraints
Limited awareness among healthcare professionals
- Opportunities
The development of targeted therapies and personalized medicine approaches
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Frasier Syndrome Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Frasier Syndrome Market , By Test Type, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Ultrasound Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

6. Frasier Syndrome Market , By End User, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Mn)

7. Frasier Syndrome Market , By Region, 2018-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 - 2030, (US$ Mn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Thermo Fisher Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Invitae Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
GE Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Mindray Medical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Siemens
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Invitae Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Canon Medical Systems Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
FUJIFILM Sonosite Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
ESAOTE SPA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
SAMSUNGHEALTHCARE
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Empire Genomics Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BPL Medical Technologies
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Trivitron Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hitachi Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us